Ilex Medical (ILX.TA) Stock Price

Ilex Medical Price

TASE·CLOSED
45.14
​
Market closed

Over the last 19 years Ilex Medical grew revenue by 9.4% annually, reaching 920.37 M ILS. Earnings per share have grown at 4.6% per year over the last 19 years. For Ilex Medical, the net margin of 4.2% is down versus 12.7% a few years ago. At today's price the dividend yield works out to roughly 3.02%. The payout ratio is around 39% of earnings. The dividend has grown at 1.2% per year over the past 18 years.

Ilex Medical stock price

Access this data via the Eulerpool API

Ilex Medical business model & stock analysis

Ilex Medical Ltd. engages in medical diagnostics field. The company is a supplier of in vitro diagnostic equipment and laboratory management software. The firm offers cutting-edge diagnostic equipment and reagent systems; nucleic acid testing (NAT) blood screening solutions; products for cancer screening, retro virus load, TB, and STDs, and other infectious diseases; laboratory information systems (LIS); and blood sugar monitoring products. Among the Company’s subsidiaries and affiliates are Ilex South Africa, Orsyx-LIS, Ilex BioTech Ltd and Medtechnica Ltd.

Frequently asked questions about Ilex Medical

Converted at the current exchange rate, the Ilex Medical share trades at 13.14 EUR (45.14 ILS).

The revenue cannot currently be calculated for Ilex Medical.

The profit cannot currently be calculated for Ilex Medical.

The P/E ratio cannot be calculated for Ilex Medical at the moment.

The P/S cannot be calculated for Ilex Medical currently.

The Eulerpool Quality Score for Ilex Medical is 3/10.

The ISIN of Ilex Medical is IL0010807530. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Ilex Medical is ILX.TA. The ticker symbol is used to trade Ilex Medical shares on the stock exchange.

Fair ValueTerminal
44.69 ILS
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Providers & Services
Number of shares
Employees
Revenue per Employee
3.61 M ILS
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Israel
Currency
ILS
Initial public offering
Jan 1, 1995
ISIN
IL0010807530
Cusip
M5362E106
Market capitalization
505.12 M ILSSmall Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
5.75
P/B Ratio
0.78
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
5.59 %
Dividend
Dividend yield
3.02 %
Payout Ratio
39.21 %
Dividend growth Ø5Y
-11.34 %
Dividend payments per year
1
Dividend paid since
5 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
25.00 %
Last updated Oct 13, 2026, 6:40 AM

Ilex Medical Peer Group

Ilex Medical Ticker

TLV · ILX.TA

Ilex Medical FIGI

ILX:IT · BBG000P7WSL6

All fundamentals and in-depth analysis of Ilex Medical

Our stock analysis for Ilex Medical stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ilex Medical. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.